Skip to main content

Soluble Tissue Factor

BRD ID: 2043
Tier: SOP
Source: TCP Project
Document: BARC PRO 026 Souble Tissue factor (TF).pdf[Size: 4692.81 KB]
Number of times downloaded: 664

Description

This document describes the protocol used by the Pathology and Laboratory Medicine Department of Boston Medical Center (BMC) to quantify levels of soluble tissue factor (sTF) in plasma by ELISA as part of the Thrombosis in Cancer Patients (TCP) Project. It is a product of the Center for Strategic Scientific Initiatives (CSSI) of the National Institutes of Health (NIH) (https://www.cancer.gov/about-nci/organization/cssi/research/past-programs#thrombosis-in-cancer-standardization-of-biomarker-measurements).